跳至主要内容
临床试验/NL-OMON21120
NL-OMON21120招募中不适用

Evaluation of effectiveness of the PlasmaJet Surgical device in the treatment of Advanced Stage Ovarian Cancer

Erasmus MC0 个研究点目标入组 330 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Erasmus MC
入组人数
330

研究概览

简要总结

Submitted

研究设计

研究类型
Interventional

入排标准

入选标准

  • patients with epithelial ovarian, tuba or peritoneal carcinoma FIGO IIIB-IV who are fit enough to undergo radical cytoreductive surgery as discussed in the multidisciplinary tumor board. Patients can either be scheduled for primary cytoreduction or for interval cytoreduction after neoadjuvant chemotherapy.
  • -patients should understand the patient information form and sign informed consent.

排除标准

  • -patients who are not willing to participate or not able to give their informed consent (language barrier) and patients who are not willing to undergo extensive surgery.
  • -patients who are unfit to undergo extensive surgery (assessed by gynaecologist and anaesthesiologist and discussed in MDO).

研究者

发起方
Erasmus MC

相似试验